Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Multivitamin study: no cure, just knowledge for healthy adults

NCT ID NCT07145658

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily multivitamin called Vitals+ improves health, mood, and thinking skills in healthy adults. Thirty-seven volunteers took either the multivitamin or a placebo for 3 months. Researchers measured blood vitamin levels, cognitive function, and gut health before and after. The goal was to see if the supplement offers any extra benefit for people who are already healthy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

37 people

The number who actually took part.

Started

Jul 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Participant has provided written informed consent before participating in the study after being given a full description of the study and prior to any study-specific procedures being performed. 2. Participant has no significant medical diagnosis (health individuals) 3. Participant takes no regular prescription medication 4. Participant is not undertaking any restrictive diet (e.g. Carnivore, Low FODMAP) 5. Participant agrees to adhere to guidance on fortified food intake for the duration of the study 6. Participant is a male or non-pregnant female and is 18-70 years of age 7. If WOCBP participant is willing to adhere to one of the following methods of contraception i) Hormonal contraception e.g. the 'pill' or an implant ii) Intrauterine device (IUD) iii) Intrauterine hormone-releasing system (IUS) iv) Hysterectomy v) Vasectomised partner vi) Sexual abstinence (if it is in line with your preferred and usual lifestyle). 8. Participant can communicate well with the Investigator and to comply with the requirements for the entire study. 9. Participant has capacity to understand written English. 10. Participant has a body mass index (BMI) of 18.5 - 39.9kg/m2 (bounds included). 11. Participant agrees to follow all pre-test preparation before L/M-HMBT testing. Exclusion Criteria: 1. Participant has consumed nutritional supplement in the past 3 months 2. Diagnosis of any current medical condition, except visual impairment and other conditions at the discretion of the investigator 3. Participated in a trial of an investigational medical product or medical device in the last 28 days. 4. Females who report to be pregnant or lactating 5. Prior abdominal surgery 6. Unwilling to maintain a stable diet for the duration of the trial. 7. Unable to comply with limiting fortified food intake to \<5 portions per week for the duration of the study 8. Being in the opinion of the investigator unsuitable 9. Insufficient knowledge of English to complete the daily bowel diary and food diary. 10. Hypersensitivity to any component of the supplement 11. Hypersensitivity or known allergy to lactulose or mannitol. 12. Consumption of oral antibiotics in the last 4 weeks. 13. NSAIDs for 2 weeks prior to and during the entire 90 day study period. Participant should not be a chronic NSAID user (\>1 day/week). 14. Gastrointestinal infection in the past 4 weeks. 15. IV vitamin/mineral therapy in the past 12 weeks 16. Use of medical devices for the purpose of cognitive enhancement, such as neural stimulation, in the 2 weeks prior or during the study period 17. Participant is involved in this study as an Investigator, sub-Investigator, study coordinator, other study staff, or Sponsor member.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The functional gut clinic

    London, NW16PU, United Kingdom

  • The functional gut clinic

    Manchester, m34bg, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.